US lenders completed over US$482bn in M&A loan volume in 2025, an increase of 43% compared to 2024 totals and the strongest results in 4 years. After a bumpy start to the year, investment grade borrowers tapped lenders for nearly US$181bn of acquisition financing an 18% increase year over year. More notable was the resurgence of high grade committed jumbo financings including dueling bridge loans backing Netflix’s and Paramount Skydance’s respective efforts to acquire Warner Bros. Discovery and a US$20bn bridge loan backing Abbott Laboratories’ purchase of Exact Sciences. In fact, during a very busy December alone, over US$70bn in high grade M&A deal flow was announced for corporates including Harbour Energy, GE Healthcare Technologies, WSP Global, all of which bodes well for 2026 according to lenders. In the leveraged arena the M&A results were less prominent, but arguably signal opportunities for 2026. At US$260bn, 2025 leveraged M&A loan volume was up 53% year over year, fueled by corporate deal activity which was up over two times year ago results at US$174.6bn. Less than US$86bn backed sponsored buyouts, a modest increase from the US$84bn raised last year. Expected financings backing large LBOs including the US$18.3bn buyout of Hologic will launch early in 2026.
Latest news
Rate hike expectations ease as term SOFR curve flattens
The CME six-month Term SOFR rate reached a recent high of 3.979% on July 28 before retreating to 3.837% as…
3Q26: New loan assets rise to 44% of total lending, a 3-year high
New loan assets as a proportion of total US loan volume make up 44% of the 3Q26 pipeline to date,…
North American GPs dominant as fundraising accelerates
Our PEI Private Credit 200 ranking also shows capital raising increasing overall – and accelerating especially fast for the largest…
